高级检索
当前位置: 首页 > 详情页

Application of network pharmacology in the study of the mechanism of action of traditional chinese medicine in the treatment of COVID-19

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Univ Tradit Chinese Med, Grad Sch, Shijiazhuang, Peoples R China [2]Hebei Univ Tradit Chinese Med, Dept Spleen & Stomach, Affiliated Hosp 1, Shijiazhuang, Peoples R China
出处:
ISSN:

关键词: network pharmacology COVID-19 mechanism of action traditional Chinese medicine pharmacology review

摘要:
Network pharmacology was rapidly developed based on multidisciplinary holistic analysis of biological systems, which has become a popular tool in traditional Chinese medicine (TCM) research in recent years. Its characteristics of integrity and systematization provide a new approach for the study on complex TCM systems, which has many similarities with the holistic concept of TCM. It has been widely used to explain the mechanism of TCM treatment of diseases, drug repositioning, and interpretation of compatibility of TCM prescriptions, to promote the modernization of TCM. The use of TCM have provided crucial support on prevention and treatment of diseases such as the famous "three medicines and three prescriptions ". Furthermore, TCM has become an important part of the treatment of COVID-19 and is one of the main contents of the "Chinese plan " to fight the epidemic. The current review demonstrated the role of TCM in treating diseases with multiple components, multiple targets, and multiple pathways, interprets the connotation of TCM treatment method selection based on pathogenesis and also discusses the application of network pharmacology in the study of COVID-19 treatment in TCM including single drug and prescription. However, there are still some shortcomings such as the lack of experimental verification and regular upgrading of the TCM pharmacology network. Therefore, we must pay attention to the characteristics of TCM and develop a network pharmacology method suitable for TCM system research when applying network pharmacology to TCM research.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 2 区 医学
小类 | 2 区 药学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 药学
JCR分区:
出版当年[2022]版:
Q1 PHARMACOLOGY & PHARMACY
最新[2024]版:
Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2024版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Hebei Univ Tradit Chinese Med, Grad Sch, Shijiazhuang, Peoples R China
通讯作者:
通讯机构: [1]Hebei Univ Tradit Chinese Med, Grad Sch, Shijiazhuang, Peoples R China [2]Hebei Univ Tradit Chinese Med, Dept Spleen & Stomach, Affiliated Hosp 1, Shijiazhuang, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:19602 今日访问量:0 总访问量:1147 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号